Monday, June 15, 2026

Kakao Mobility Builds Robot Platform to Integrate Delivery, Cleaning and Logistics Services

Kakao Mobility is developing a unified robot platform for various services, enhancing integration and communication with users.

South Korea Softens Inter-Korean Policy, But North Korea Remains Unmoved

The Lee administration is taking steps to ease tensions with North Korea, but faces indifference from the North, raising concerns.

North Korea Builds Luxury Tour Center to Celebrate ‘Super Moms’

North Korea establishes a new women's propaganda group tour site in Pyongyang to boost morale among women.

Tag: Zymfentra

Celltrion’s Zymfentra Just Hit a New U.S. Prescription Record and the Growth Looks Serious

Celltrion's Zymfentra treatment saw a 185% surge in U.S. prescriptions, driven by effective marketing and reimbursement strategies.

How Celltrion’s Local Production Strategy Eliminates U.S. Drug Tariffs Influence

Celltrion resolves tariff impacts on U.S. sales, boosting local production and growth opportunities for its biosimilars, including Zymfentra.

How Zymfentra’s Prescription Rates Tripled in January: A Game-Changer for Celltrion

Celltrion's Zymfentra sees a 213% rise in U.S. prescriptions, marking significant growth since its launch, driven by market demand.

Celltrion’s Zymfentra: How This Breakthrough Drug is Driving Record Sales

Celltrion expects record sales driven by Zymfentra's success, expanding into new biosimilars and CDMO business for future growth.

K-Bio Targets the U.S. Market: Celltrion and Samsung Bioepis Close in on Originator Drugs

Celltrion and Samsung Bioepis are expanding in the U.S. market, showing strong growth in biosimilars like Zymfentra and Hadlima.

Top News

- Our Sponsors Ad -

Follow us